{ "ok": true, "cik": "788920", "ticker": "PDEX", "name": "PRO-DEX, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-18", "items": [ "1.01 Entry into a Material Definitive Agreement", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326001261/0001079973-26-001261-index.htm" }, { "form": "8-K", "filed": "2026-09-03", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326001216/0001079973-26-001216-index.htm" }, { "form": "10-K", "filed": "2026-09-03", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326001215/0001079973-26-001215-index.htm" }, { "form": "8-K", "filed": "2026-08-28", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326001196/0001079973-26-001196-index.htm" }, { "form": "8-K", "filed": "2026-06-17", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326000854/0001079973-26-000854-index.htm" }, { "form": "8-K", "filed": "2026-04-30", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997326000581/0001079973-26-000581-index.htm" } ], "events12m": 11, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000788920.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=788920" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up PRO-DEX, INC. ($PDEX). Last filing: 8-K (1.01 Entry into a Material Definitive Agreement), 2026-09-18. 11 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2025-06-05.", "auditor": { "changes": [ { "filed": "2025-06-05", "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997325000990/0001079973-25-000990-index.htm" } ], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2026-06-30", "revenue": 77548000, "revenueGrowth1y": 0.16450677999189112, "revenueGrowthPerYear": 0.16539832881005778, "yearsOfData": 5, "operatingMargin": 0.16752205085882294, "operatingMarginPrior": 0.1605123661646119, "netMargin": 0.17617475627998144, "operatingCashFlow": 7242000, "capitalSpending": 483000, "freeCashFlow": 6759000, "researchAndDevelopment": 3345000, "researchShareOfRevenue": 0.043134574715015216, "cash": 8192000, "longTermDebt": 17513000, "longTermDebtChange": 0.13492320653230516, "revenueHistory": [ { "fiscalYearEnd": "2022-06-30", "revenue": 42041000 }, { "fiscalYearEnd": "2023-06-30", "revenue": 46087000 }, { "fiscalYearEnd": "2024-06-30", "revenue": 53844000 }, { "fiscalYearEnd": "2025-06-30", "revenue": 66593000 }, { "fiscalYearEnd": "2026-06-30", "revenue": 77548000 } ], "totalEquity": 47633000, "totalAssets": 74509000, "equityRatio": 0.6392918976231059, "returnOnEquity": 0.28681796233703527, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 66983550.15221645, "high": 120276498.69272494, "baseline": 91270677.41138636, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 66983550.15221645, "high": 120276498.69272494 } }, "edgarette": "🔖 Exposure: revenue $77.5M (FY2026), total debt $17.5M. Experience: revenue up 16.5% on the year, up 16.5% a year over 4 years; operating margin 16.8%, up from 16.1%. Soundness: equity 63.9% of assets, return on equity 28.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $67.0M and $120.3M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin 16.8% against a 1.2% median; growth 16.5% against 11.6%.", "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "summary": "Pro-Dex (PDEX) grew revenue 16.5% in FY2026 to $78 million, operating margin 16.8% against a 1.2% median for surgical & medical instruments & apparatus, equity 63.9% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
PRO-DEX, INC. against its own record and its peers
Operating marginPeer median 1.2%16.8%Revenue, on the yearPeer median 11.6%16.5%Equity of assetsPeer median 52.9%63.9%Return on equityPeer median -2.3%28.7%Gold tick: the median of 55–59 peers with $50M+ revenue in surgical & medical instruments & apparatus
", "chartHorizon": null, "backtest": { "tests": 12, "hits": 10, "rate": 0.8333333333333334, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:22:36.695Z", "hash": "f11b5995e1eb9eba", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Pro-Dex (PDEX) grew revenue 16.5% in FY2026 to $78 million, operating margin 16.8% against a 1.2% median for surgical & medical instruments & apparatus, equity 63.9% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2026-06-30", "revenue": 77548000, "totalDebt": 17513000, "cash": 8192000 }, "experience": { "revenueGrowth1y": 0.16450677999189112, "revenueGrowthPerYear": 0.16539832881005778, "operatingMargin": 0.16752205085882294, "operatingMarginPrior": 0.1605123661646119, "netMargin": 0.17617475627998144, "freeCashFlow": 6759000 }, "soundness": { "equityRatio": 0.6392918976231059, "returnOnEquity": 0.28681796233703527, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "calendarYear": 2025, "minRevenue": 50000000, "depth": 4, "group": "3841", "growth": [ 0.1161, 60 ], "opMargin": [ 0.0124, 60 ], "equityRatio": [ 0.5291, 59 ], "returnOnEquity": [ -0.0233, 55 ], "payoutRatio": [ 0.3812, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": { "filed": "2025-06-05", "url": "https://www.sec.gov/Archives/edgar/data/788920/000107997325000990/0001079973-25-000990-index.htm" } }, "range": { "low": 66983550.15221645, "high": 120276498.69272494, "baseline": 91270677.41138636, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 12, "hits": 10, "rate": 0.8333333333333334, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:22:36.695Z", "hash": "f11b5995e1eb9eba", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000788920.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=788920" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }